Moore Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-126,806
Closed -$11.4M 836
2025
Q4
$11.4M Buy
126,806
+19,261
+18% +$1.83M 0.16% 143
2025
Q3
$10.6M Sell
107,545
-31,185
-22% -$3.09M 0.15% 141
2025
Q2
$12.7M Buy
138,730
+80,777
+139% +$7.81M 0.16% 111
2025
Q1
$6.56M Buy
57,953
+10,834
+23% +$1.16M 0.14% 153
2024
Q4
$4.98M Buy
+47,119
New +$5.06M 0.06% 253
2023
Q2
Sell
-69,300
Closed -$8.95M 609
2023
Q1
$8.95M Buy
+69,300
New +$8.7M 0.19% 101
2022
Q1
Sell
-41,355
Closed -$5.1M 867
2021
Q4
$5.1M Sell
41,355
-117,003
-74% -$15.3M 0.1% 197
2021
Q3
$22.5M Buy
158,358
+133,270
+531% +$19.6M 0.34% 63
2021
Q2
$3.92M Sell
25,088
-53,114
-68% -$8.6M 0.06% 329
2021
Q1
$12.2M Sell
78,202
-69,578
-47% -$10.8M 0.15% 113
2020
Q4
$22.1M Buy
147,780
+77,179
+109% +$10.9M 0.24% 64
2020
Q3
$9.33M Buy
+70,601
New +$9.22M 0.18% 121
2016
Q1
Sell
-113,300
Closed -$11.3M 351
2015
Q4
$11.3M Buy
113,300
+72,100
+175% +$7.05M 0.35% 80
2015
Q3
$3.76M Buy
+41,200
New +$4.13M 0.18% 164
2014
Q4
Sell
-159,650
Closed -$15.6M 425
2014
Q3
$15.6M Buy
+159,650
New +$15.7M 0.36% 67

Other funds holding ZBH

Moore Capital Management's ZBH Position: Q1 2026 in Review

Moore Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 126,806 shares — an estimated $11.4M sold.

Moore Capital Management first reported a position in ZBH in Q3 2014 and held it in 15 quarters. The position peaked at $22.5M in Q3 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Moore Capital Management reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Moore Capital Management sold 126,806 Zimmer Biomet shares in Q1 2026, an estimated $11.4M.
  • Moore Capital Management first reported a position in Zimmer Biomet in Q3 2014 and held it in 15 quarters.
  • Moore Capital Management's Zimmer Biomet position peaked at $22.5M in Q3 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.